BRIEF published on 12/11/2024 at 18:05, 1 year 9 months ago The Eiffel Tower Company reorganizes its portfolio with the sale in Marseille Real Estate Market Eiffel Tower Society Environmental Certification Real Estate Transfer Wealth Strategy
BRIEF published on 12/05/2024 at 18:55, 1 year 9 months ago Eiffel Tower Company: 2024 Outlook and Financial Strategies Real Estate Capital Increase Financial Strategy Eiffel Tower Society Occupancy Rate
BRIEF published on 12/05/2024 at 18:45, 1 year 9 months ago Financial Evolution of the Eiffel Tower Company in 2024 Capital Increase Commercial Real Estate Financial Strategy Occupancy Rate Declining Assets
BRIEF published on 12/03/2024 at 18:05, 1 year 9 months ago Number of shares and voting rights of the Société de la Tour Eiffel as of November 30, 2024 Financial Information Share Capital Voting Rights Actions Eiffel Tower Society
BRIEF published on 11/25/2024 at 18:05, 1 year 9 months ago Eiffel Tower Company: Preparatory Documents for the 2024 Extraordinary General Meeting Available Shareholders Transparency General Meeting Resolutions Preparatory Documents
BRIEF published on 11/06/2024 at 18:05, 1 year 10 months ago Eiffel Tower Company: Planned capital increase of 600 million euros Capital Increase General Assembly Eiffel Tower Society SMABTP Group Banking Covenants
BRIEF published on 11/04/2024 at 18:05, 1 year 10 months ago Eiffel Tower Company: Details on Shares and Voting Rights Share Capital Voting Rights Actions Regulation Financial Markets
BRIEF published on 10/01/2024 at 18:05, 1 year 11 months ago Société de la Tour Eiffel - Number of shares and voting rights as of September 30, 2024 Share Capital Voting Rights Actions 2024 Eiffel Tower Society
BRIEF published on 09/05/2024 at 18:05, 2 years ago STE: Number of shares and voting rights as of August 31, 2024 Financial Information Share Capital Voting Rights Eiffel Tower Society STE Actions
BRIEF published on 08/01/2024 at 18:05, 2 years 1 month ago Number of shares and voting rights as of July 31, 2024 for the Société de la Tour Eiffel Share Capital Voting Rights Actions Eiffel Tower Society July 2024
Published on 09/17/2026 at 15:55, 3 hours 29 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 3 hours 59 minutes ago AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 15:00, 4 hours 24 minutes ago Norsemont Hits 41 Meters of 4.59 g/t Gold as Phase 3 Drilling Continues to Expand the Choquelimpie System
Published on 09/17/2026 at 15:00, 4 hours 24 minutes ago ECC Ventures 4 Announces Termination of Agreement With Cambria Gold Mines Inc.
Published on 09/17/2026 at 14:50, 4 hours 34 minutes ago Caldwell Strengthens Human Resources Practice with Addition of Ali Palmer as Partner
Published on 09/17/2026 at 19:00, 23 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 25 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 58 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 1 hour 13 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 1 hour 37 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 1 hour 44 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 1 hour ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 12 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
